The effectiveness of tamsulosin in preventing urinary disorders in coloproctological patients with BPH
Over the last decades there has been an increase in the growth of diseases of the rectum and colon. However, only in the United States each year revealed about 135 000 new cases of colorectal cancer. In two-thirds of the observations are localized tumors in the colon and in one third of cases – in a straight line. The risk of developing colorectal tumors in their lifetime is 5.9% of the total population.
One of the main forms of treatment such coloproctological pathology as anal fissures, hemorrhoids, swelling of rectum and colon is surgery. In connection with this pressing issue is the prevention of urinary disorders in the early postoperative period in these patients.
Results of the survey of patients showed that patients treated for five days before surgery and ten days after surgery tamsulosin 0.4 mg, there was no violation of the act of urination in the early postoperative period.
Use of the drug tamsulosin in patients with diseases of the rectum and sigmoid for five days before and ten days after surgery at a dose of 0.4 mg once daily is appropriate and justified, because the background of the drug occurs a significant reduction in obstructive and irritative symptoms of prostate cancer.